Genomic and proteomic studies suggest that KRT17 is highly expressed in most malignant tumor tissues or cells (Kim et al., 2013; Zhang et al., 2011; Kim et al., 2012; Takenami et al., 2019), and this high expression is related to tumour growth, metastasis and prognosis. This evidence concerns the gene KRT17 and neoplasm.